Table 2.
Multivariate analysis of various prognostic factors in patients with NSCLC
| Univariate | Multivariate | |||
| Prognostic factor | P value | β | P value | Relative Risk (95%) CI) | 
| ptLVD (high/low) | 0.0001 | 0.828 | 0.003 | 2.288 (1.182–4.428) | 
| Pathologic stage(I+II/III+IV) | 0.0000 | 1.310 | 0.003 | 3.708 (1.581–8.694) | 
| Pathologic N stage (N0/N2–3) | 0.0000 | 1.218 | 0.010 | 3.382 (1.344–8.511) | 
| LVI (-/+) | 0.0002 | 0.714 | 0.052 | 2.041 (0.993–4.196) | 
| VEGF-C(-/+) | 0.0054 | -0.365 | 0.490 | 0.694 (0.246–1.958) | 
| Ki67% | 0.0012 | 0.726 | 0.032 | 2.067 (1.026–4.161) | 
(LVI: lymphatic vessel invasion, ptLVD: peritumoral lymphatic vessel density, Ki67/%: Ki-67 index of the endothelium cells of the micro lymphatic vessels)